(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -106.34%-56.59M | 263.58%501.73M | 77.92%-149.89M | -164.18%-580.18M | -255.82%-486.47M | 164.96%891.85M | -572.64%-306.73M | -463.05%-678.83M | 865.16%903.98M | 424.97%312.19M |
Net income from continuing operations | -30.77%34.1M | -338.48%-117.55M | -28.18%37.28M | -20.08%181.09M | -44.97%30.62M | -11.82%49.26M | -17.23%49.29M | -6.50%51.91M | 297.03%226.58M | 154.09%55.65M |
Depreciation and amortization | -1.88%14.15M | 9.47%15.89M | 12.20%16.09M | 14.28%59.98M | 23.81%16.71M | 8.67%14.42M | 12.41%14.51M | 11.92%14.34M | -14.68%52.48M | 3.07%13.49M |
Asset impairment expenditure | 2,716.67%169K | 327,181.36%193.1M | 1,633.33%416K | -11.55%3.44M | 13.53%3.35M | 0.00%6K | -29.76%59K | -97.17%24K | -97.62%3.89M | -98.19%2.95M |
Provision for loans, leases and other losses | 22.09%16.28M | 10.90%17.93M | 9.50%16.9M | 8.31%61.61M | -6.61%16.67M | -19.80%13.34M | 24.38%16.17M | 64.17%15.43M | 14.91%56.88M | -28.32%17.85M |
Deferred tax | 10.73%-1.93M | -535.18%-52.52M | -68.32%-14.49M | -187.07%-18.63M | 103.96%408K | 48.13%-2.16M | -327.11%-8.27M | -297.93%-8.61M | 70.58%-6.49M | 78.62%-10.31M |
Change in working capital | -114.61%-119.36M | 217.54%444.89M | 72.59%-206.1M | -252.05%-867.66M | -338.31%-554.22M | 220.39%816.99M | -1,458.41%-378.49M | -822.66%-751.94M | 364.62%570.64M | 259.03%232.56M |
-Change in loans | 95.27%2.23B | -77.00%162.24M | 215.41%1.23B | 121.45%874.29M | 245.92%88.82M | 160.93%1.14B | 158.34%705.48M | -14.46%-1.06B | -410.75%-4.08B | 89.56%-60.87M |
-Change in other working capital | -620.86%-2.35B | 126.08%282.65M | -560.39%-1.43B | -137.49%-1.74B | -377.96%-643.04M | -115.25%-326.25M | -190.16%-1.08B | -70.91%311.31M | 426.42%4.65B | -48.27%231.34M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -106.34%-56.59M | 263.58%501.73M | 77.92%-149.89M | -164.18%-580.18M | -255.82%-486.47M | 164.96%891.85M | -572.64%-306.73M | -463.05%-678.83M | 865.16%903.98M | 424.97%312.19M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 111.01%93.47M | -253.45%-481.6M | -73.76%180.85M | 187.64%665.23M | 268.86%510.98M | -1,744.15%-848.89M | 190.32%313.84M | 529.29%689.3M | -4,468.36%-759.03M | -402.43%-302.6M |
Proceeds payment in interest bearing deposits in bank | 140.55%309.06M | -352.78%-878.1M | 40.45%625.28M | 146.20%560.39M | 255.69%530.07M | -139.07%-762.26M | 302.42%347.38M | 216.49%445.2M | -24,074.31%-1.21B | -533.85%-340.46M |
Net PPE purchase and sale | -18.86%-10.14M | -8.57%-9.46M | 23.90%-7.67M | 38.62%-38.7M | 62.09%-11.38M | 46.25%-8.53M | 16.43%-8.72M | -49.53%-10.08M | -124.33%-63.05M | -98.22%-30.02M |
Net investment purchase and sale | -163.04%-205.45M | 1,735.45%405.97M | -271.83%-436.76M | -36.32%143.53M | -111.37%-7.72M | -125.06%-78.11M | 93.51%-24.82M | 11.31%254.18M | 1,820.64%225.39M | 294.63%67.87M |
Net proceeds payment for loan | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 1,393.82%291.73M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 111.01%93.47M | -253.45%-481.6M | -73.76%180.85M | 187.64%665.23M | 268.86%510.98M | -1,744.15%-848.89M | 190.32%313.84M | 529.29%689.3M | -4,468.36%-759.03M | -402.43%-302.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -26.68%-31.76M | -25.23%-25.67M | -27.64%-33.18M | 34.31%-97.08M | -6.73%-25.52M | 93.29%-25.07M | -107.11%-20.5M | 25.64%-25.99M | -100.39%-147.8M | -295.27%-23.91M |
Net issuance payments of debt | -153.24%-8.33M | -252.26%-6.15M | -118.13%-10.36M | 49.99%-15.71M | 14.82%-5.92M | 99.06%-3.29M | -100.53%-1.75M | 0.27%-4.75M | -59.26%-31.41M | -45.69%-6.95M |
Net commonstock issuance | -97.19%18K | -116.67%-4K | -100.00%-12K | 104.27%664K | -99.67%5K | 9,257.14%641K | 100.52%24K | 99.95%-6K | -32,533.33%-15.57M | 7,085.71%1.51M |
Cash dividends paid | -1.35%-22.69M | -2.78%-19.52M | -3.19%-22.81M | 16.37%-83.08M | -2.89%-19.6M | 4.55%-22.39M | 50.16%-18.99M | -43.31%-22.1M | -88.51%-99.34M | -1,410.71%-19.05M |
Net other financing activities | -2,120.59%-755K | ---- | ---- | 169.99%1.04M | --0 | 10.53%-34K | -21.43%209K | 137.57%863K | -101.20%-1.48M | 1,683.78%586K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -26.68%-31.76M | -25.23%-25.67M | -27.64%-33.18M | 34.31%-97.08M | -6.73%-25.52M | 93.29%-25.07M | -107.11%-20.5M | 25.64%-25.99M | -100.39%-147.8M | -295.27%-23.91M |
Net cash flow | ||||||||||
Beginning cash position | 18.99%61.79M | 1.96%64.89M | -12.88%69.44M | 15.51%79.7M | -20.12%66.69M | -25.61%51.93M | 0.20%63.65M | 15.51%79.7M | -0.95%69M | 16.27%83.49M |
Current changes in cash | -71.37%5.12M | 58.62%-5.54M | 85.70%-2.22M | -321.95%-12.03M | 92.97%-1.01M | 24.90%17.89M | -335.63%-13.39M | -81.79%-15.53M | -186.74%-2.85M | -595.05%-14.32M |
Effect of exchange rate changes | 107.55%236K | 45.75%2.44M | -339.70%-2.33M | -86.94%1.77M | -64.36%3.75M | -384.81%-3.13M | 177.74%1.67M | -117.28%-529K | 443.35%13.55M | 1,515.86%10.53M |
End cash position | 0.68%67.15M | 18.99%61.79M | 1.96%64.89M | -12.88%69.44M | -12.88%69.44M | -20.12%66.69M | -25.61%51.93M | 0.20%63.65M | 15.51%79.7M | 15.51%79.7M |
Free cash from | -107.55%-66.72M | 256.06%492.27M | 77.13%-157.56M | -173.59%-618.88M | -276.43%-497.85M | 175.41%883.33M | -679.14%-315.44M | -482.21%-688.91M | 1,182.77%840.93M | 353.72%282.17M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data